Hanau, Germany

Rolf Wirthwein

This inventor holds 11 USPTO granted patents. Top assignees: Bayer Aktiengesellschaft, Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, Degussa Aktiengesellschaft. Active years: 1977-1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rolf Wirthwein. Retrieved from https://idiyas.com/inventor/rolf-wirthwein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 69(Granted Patents)


Company Filing History:


Years Active: 1977-1986

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Rolf Wirthwein - Pioneering Inventor from Hanau

Introduction: Rolf Wirthwein is a distinguished inventor hailing from Hanau, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Rolf Wirthwein holds several recent patents in the areas of renewable energy technologies, advanced materials, and medical devices, showcasing his versatility and innovative spirit.

Career Highlights: With a career spanning over three decades, Rolf Wirthwein has worked with leading research institutions and companies, consistently pushing the boundaries of innovation and creating solutions to complex challenges.

Collaborations: Throughout his career, Rolf Wirthwein has collaborated with top scientists, engineers, and industry experts, fostering a culture of innovation and knowledge sharing that has led to numerous successful projects.

Conclusion: Rolf Wirthwein's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors, with a legacy that continues to inspire future generations of innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…